Prevalence of Medication Use in Children for Cardiometabolic Risk Reduction

Research output: Contribution to journalArticle

Abstract

Recently there has been concern regarding the prevalence of medication use in children to manage the same cardiometabolic risk factors that traditionally begin in adulthood, but are now more prevalent in children. Two studies have been published reporting the actual prevalence of medication use in children to treat the conditions of high blood pressure, high cholesterol, and diabetes. Both studies report that the overall prevalence of medication use among children to manage these conditions is increasing. Concurrently, physical activity levels and healthy eating habits in children are decreasing and the incidence of obesity is increasing. Although medications used to treat cardiometabolic risks are important for preventing future cardiovascular disease, greater resources should be dedicated toward lifestyle medicine-related treatment and prevention efforts in this population to improve the future health of these individuals and the general health of America.

Original languageEnglish
Pages (from-to)310-312
Number of pages3
JournalAmerican Journal of Lifestyle Medicine
Volume7
Issue number5
DOIs
StatePublished - Sep 2013

Fingerprint

Risk Reduction Behavior
Health
Feeding Behavior
Life Style
Cardiovascular Diseases
Obesity
Cholesterol
Medicine
Exercise
Hypertension
Incidence
Population

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Prevalence of Medication Use in Children for Cardiometabolic Risk Reduction. / Lenz, Thomas L.

In: American Journal of Lifestyle Medicine, Vol. 7, No. 5, 09.2013, p. 310-312.

Research output: Contribution to journalArticle

@article{3606be2119e54324b3d4e344369575d6,
title = "Prevalence of Medication Use in Children for Cardiometabolic Risk Reduction",
abstract = "Recently there has been concern regarding the prevalence of medication use in children to manage the same cardiometabolic risk factors that traditionally begin in adulthood, but are now more prevalent in children. Two studies have been published reporting the actual prevalence of medication use in children to treat the conditions of high blood pressure, high cholesterol, and diabetes. Both studies report that the overall prevalence of medication use among children to manage these conditions is increasing. Concurrently, physical activity levels and healthy eating habits in children are decreasing and the incidence of obesity is increasing. Although medications used to treat cardiometabolic risks are important for preventing future cardiovascular disease, greater resources should be dedicated toward lifestyle medicine-related treatment and prevention efforts in this population to improve the future health of these individuals and the general health of America.",
author = "Lenz, {Thomas L.}",
year = "2013",
month = "9",
doi = "10.1177/1559827613492088",
language = "English",
volume = "7",
pages = "310--312",
journal = "American Journal of Lifestyle Medicine",
issn = "1559-8276",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Prevalence of Medication Use in Children for Cardiometabolic Risk Reduction

AU - Lenz, Thomas L.

PY - 2013/9

Y1 - 2013/9

N2 - Recently there has been concern regarding the prevalence of medication use in children to manage the same cardiometabolic risk factors that traditionally begin in adulthood, but are now more prevalent in children. Two studies have been published reporting the actual prevalence of medication use in children to treat the conditions of high blood pressure, high cholesterol, and diabetes. Both studies report that the overall prevalence of medication use among children to manage these conditions is increasing. Concurrently, physical activity levels and healthy eating habits in children are decreasing and the incidence of obesity is increasing. Although medications used to treat cardiometabolic risks are important for preventing future cardiovascular disease, greater resources should be dedicated toward lifestyle medicine-related treatment and prevention efforts in this population to improve the future health of these individuals and the general health of America.

AB - Recently there has been concern regarding the prevalence of medication use in children to manage the same cardiometabolic risk factors that traditionally begin in adulthood, but are now more prevalent in children. Two studies have been published reporting the actual prevalence of medication use in children to treat the conditions of high blood pressure, high cholesterol, and diabetes. Both studies report that the overall prevalence of medication use among children to manage these conditions is increasing. Concurrently, physical activity levels and healthy eating habits in children are decreasing and the incidence of obesity is increasing. Although medications used to treat cardiometabolic risks are important for preventing future cardiovascular disease, greater resources should be dedicated toward lifestyle medicine-related treatment and prevention efforts in this population to improve the future health of these individuals and the general health of America.

UR - http://www.scopus.com/inward/record.url?scp=84887539512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887539512&partnerID=8YFLogxK

U2 - 10.1177/1559827613492088

DO - 10.1177/1559827613492088

M3 - Article

AN - SCOPUS:84887539512

VL - 7

SP - 310

EP - 312

JO - American Journal of Lifestyle Medicine

JF - American Journal of Lifestyle Medicine

SN - 1559-8276

IS - 5

ER -